We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+23.89%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.31B
AUM Growth
+$185M
Cap. Flow
-$116M
Cap. Flow %
-8.83%
Top 10 Hldgs %
20.65%
Holding
244
New
31
Increased
70
Reduced
38
Closed
33

Top Buys

Rank Stock Value
1
ROAD icon
Construction Partners
ROAD
+$14.3M
2
MOD icon
Modine Manufacturing
MOD
+$8.42M
3
PIPR icon
Piper Sandler
PIPR
+$6.88M
4
MC icon
Moelis & Co
MC
+$6.78M
5
RVMD icon
Revolution Medicines
RVMD
+$6.06M

Top Sells

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$18.8M
2
ADMA icon
ADMA Biologics
ADMA
+$10.3M
3
VHT icon
Vanguard Health Care ETF
VHT
+$9.45M
4
SFM icon
Sprouts Farmers Market
SFM
+$9.21M
5
ARIS
Aris Water Solutions
ARIS
+$8.81M

Sector Composition

Rank Sector Weight
1 Industrials 23.91%
2 Technology 20.96%
3 Healthcare 12.12%
4 Financials 9.83%
5 Consumer Discretionary 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KVYO icon
126
Klaviyo
KVYO
$4.73B
$2.87M 0.22%
103,619
+1,709
+2% +$55.2K
CWST icon
127
Casella Waste Systems
CWST
$5.69B
$2.85M 0.22%
30,065
-60,740
-67% -$6.11M
FOUR icon
128
Shift4
FOUR
$3.26B
$2.85M 0.22%
36,823
-8,616
-19% -$801K
NFG icon
129
National Fuel Gas
NFG
$7.65B
$2.81M 0.22%
+30,464
New +$2.66M
TFII icon
130
TFI International
TFII
$11.5B
$2.71M 0.21%
30,828
-10,190
-25% -$932K
ORIC icon
131
Oric Pharmaceuticals
ORIC
$1.4B
$2.65M 0.2%
220,735
+146,493
+197% +$1.54M
CACI icon
132
CACI
CACI
$14.2B
$2.48M 0.19%
4,979
– –
XYL icon
133
Xylem
XYL
$28.1B
$2.3M 0.18%
+15,600
New +$2.16M
DINO icon
134
HF Sinclair
DINO
$14.5B
$2.21M 0.17%
42,150
+26,800
+175% +$1.27M
NLY icon
135
Annaly Capital Management
NLY
$17.4B
$2.16M 0.17%
106,805
– –
VRT icon
136
Vertiv
VRT
$105B
$2.08M 0.16%
13,795
– –
STUB
137
StubHub Holdings
STUB
$3.36B
$1.99M 0.15%
+118,129
New +$2.17M
ESTC icon
138
Elastic
ESTC
$7.81B
$1.95M 0.15%
23,088
-16,346
-41% -$1.38M
COP icon
139
ConocoPhillips
COP
$141B
$1.89M 0.14%
20,000
– –
PANW icon
140
Palo Alto Networks
PANW
$297B
$1.8M 0.14%
8,845
+392
+5% +$75K
RMBS icon
141
Rambus
RMBS
$11B
$1.73M 0.13%
+16,630
New +$1.28M
ADMA icon
142
ADMA Biologics
ADMA
$2.22B
$1.7M 0.13%
116,259
-602,017
-84% -$10.3M
ABVX
143
Abivax
ABVX
$11.4B
$1.65M 0.13%
+19,428
New +$1.19M
SN icon
144
SharkNinja
SN
$26.1B
$1.54M 0.12%
14,888
+811
+6% +$92.6K
ASML icon
145
ASML
ASML
$669B
$1.48M 0.11%
1,531
-482
-24% -$379K
ORCL icon
146
Oracle
ORCL
$423B
$1.43M 0.11%
5,100
– –
SHOP icon
147
Shopify
SHOP
$195B
$1.42M 0.11%
9,569
– –
AS icon
148
Amer Sports
AS
$21.4B
$1.42M 0.11%
40,799
+20,947
+106% +$790K
EVR icon
149
Evercore
EVR
$11.8B
$1.39M 0.11%
4,108
+1,753
+74% +$549K
LRCX icon
150
Lam Research
LRCX
$390B
$1.35M 0.1%
10,104
-679
-6% -$71.9K
4 5
6
7 8

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Nicholas Investment Partners held 244 positions worth $1.31B, up 16% from $1.12B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Nicholas Investment Partners withdrew a net $116M in Q3 2025, closing 33 positions and reducing 38 holdings. Its most notable exit was Verona Pharma, an estimated $18.8M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 24% of assets, up from 22% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Nicholas Investment Partners opened a new position in Construction Partners worth $15.9M.

  • Nicholas Investment Partners's largest Q3 2025 buy was Construction Partners: 125,417 shares worth $15.9M.
  • Nicholas Investment Partners added most to Piper Sandler in Q3 2025, an estimated $6.88M increase.
  • Nicholas Investment Partners's biggest Q3 2025 reduction was ADMA Biologics, cutting an estimated $10.3M.
  • Nicholas Investment Partners fully exited Verona Pharma in Q3 2025, selling an estimated $18.8M.
  • Nicholas Investment Partners's ten largest holdings make up 21% of its $1.31B portfolio in Q3 2025.
  • Nicholas Investment Partners opened 31 new positions and closed 33 in Q3 2025.
  • Nicholas Investment Partners's portfolio value rose 16% quarter-over-quarter to $1.31B.

Based on Nicholas Investment Partners's 13F filing for Q3 2025, filed 14 Nov 2025.